Literature DB >> 3355495

Serum concentrations of the N-terminal propeptide of type III procollagen and two type IV collagen fragments and gene expression of the respective collagen types in liver in rats with dimethylnitrosamine-induced hepatic fibrosis.

E R Savolainen1, D Brocks, L Ala-Kokko, K I Kivirikko.   

Abstract

Dimethylnitrosamine (DMN)-induced liver fibrosis was used as an experimental model to study the relationship between serum concentrations of the N-terminal propeptide of type III procollagen [S-Pro(III)-N-P] and the N-terminal (S-7S) and C-terminal (S-NC1) domains of type IV collagen and hepatic concentrations of type III and IV collagen mRNAs. Increases in S-Pro(III)-N-P, and especially in the two type IV collagen-related antigens, were found to be early events in the formation of DMN-induced hepatic fibrosis. The mean concentration of S-Pro(III)-N-P was 120% of the control mean on day 7 of DMN treatment, 230% on day 14 and 250% on day 21. The corresponding values for S-7S were 260, 950 and 1100% and, for S-NC1, 310, 820 and 1000%. All these changes were very similar to those found in the hepatic concentrations of the respective mRNAs. These data support a previous suggestion that an enhanced production of basement-membrane (type IV) collagen is an early event in the development of the DMN-induced hepatic fibrosis. The results also indicate that S-7S and S-NC1 are very sensitive indicators of changes in type IV collagen metabolism. Data obtained in gel-filtration experiments for these three serum antigens were consistent with the suggestion that all three antigens are mainly derived from the synthesis of the respective collagens.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355495      PMCID: PMC1148770          DOI: 10.1042/bj2490753

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  cDNA clones coding for the pro-alpha1(IV) chain of human type IV procollagen reveal an unusual homology of amino acid sequences in two halves of the carboxyl-terminal domain.

Authors:  T Pihlajaniemi; K Tryggvason; J C Myers; M Kurkinen; R Lebo; M C Cheung; D J Prockop; C D Boyd
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

Review 2.  Liver fibrosis.

Authors:  M Rojkind; R Pérez-Tamayo
Journal:  Int Rev Connect Tissue Res       Date:  1983

3.  Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.

Authors:  O Niemelä; L Risteli; E A Sotaniemi; J Risteli
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

4.  Immunochemical and autoantigenic properties of the globular domain of basement membrane collagen (type IV).

Authors:  H von der Mark; I Oberbäumer; R Timpl; R Kemler; G Wick
Journal:  Eur J Biochem       Date:  1985-02-01

5.  Radioimmunoassay for type III procollagen peptide and its application to human liver disease.

Authors:  H Rohde; L Vargas; E Hahn; H Kalbfleisch; M Bruguera; R Timpl
Journal:  Eur J Clin Invest       Date:  1979-12       Impact factor: 4.686

6.  Procollagen IV. Association to tetramers.

Authors:  K G Duncan; L I Fessler; H P Bächinger; J H Fessler
Journal:  J Biol Chem       Date:  1983-05-10       Impact factor: 5.157

7.  Molecular cloning and carboxyl-propeptide analysis of human type III procollagen.

Authors:  H R Loidl; J M Brinker; M May; T Pihlajaniemi; S Morrow; J Rosenbloom; J C Myers
Journal:  Nucleic Acids Res       Date:  1984-12-21       Impact factor: 16.971

8.  Type IV collagen antigens in serum of rats with experimental fibrosis of the liver.

Authors:  D G Brocks; M Bickel; K Engelbart
Journal:  Alcohol Alcohol Suppl       Date:  1987

9.  Type IV collagen and laminin-related antigens in human serum in alcoholic liver disease.

Authors:  O Niemelä; L Risteli; E A Sotaniemi; J Risteli
Journal:  Eur J Clin Invest       Date:  1985-06       Impact factor: 4.686

10.  Type IV collagen antigens in serum of diabetic rats: a marker for basement membrane collagen biosynthesis.

Authors:  D G Brocks; H P Neubauer; H Strecker
Journal:  Diabetologia       Date:  1985-12       Impact factor: 10.122

View more
  3 in total

1.  Localisation and semiquantitative assessment of hepatic procollagen mRNA in primary biliary cirrhosis.

Authors:  C J Goddard; A Smith; J A Hoyland; P Baird; R F McMahon; A J Freemont; M Shomaf; N Y Haboubi; T W Warnes
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

2.  Comprehensive characterization of serum clinical chemistry parameters and the identification of urinary superoxide dismutase in a carbon tetrachloride-induced model of hepatic fibrosis in the female Hanover Wistar rat.

Authors:  Rosemary Smyth; Michael R Munday; Malcolm J York; Christopher J Clarke; Theo Dare; John A Turton
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

3.  Protective effect of morin on dimethylnitrosamine-induced hepatic fibrosis in rats.

Authors:  Hee-Seung Lee; Kyung Hee Jung; In-Suh Park; Sung Won Kwon; Don-Haeng Lee; Soon-Sun Hong
Journal:  Dig Dis Sci       Date:  2008-07-17       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.